Here, we established a fully automatic and high-throughput electrochemiluminescence immunoassay (ECLIA) to measure IgM-free AIM and investigated its efficacy in diagnosing NASH-HCC and viral HCC. The gene discussed is CD40LG; the disease is metabolic dysfunction-associated steatohepatitis.